Neudle.com: tumor necrosis factor

Differential
(Click to cross reference)

abciximab

abdominal reflex, absent

abortion, spontaneous

acetylcholine receptor

acetylcholine receptor antibody

acoustic neurinoma

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome, congenital

acquired immunodeficiency syndrome, infants and children

acyclovir

adalimumab

aducanumab

advances in neurology

adverse drug reaction

Alzheimer's disease, early onset

Alzheimer's disease, treatment of

amblyopia, toxic

AMPA receptor antibodies

amyloid

amyloid beta protein

amyloid beta protein antibodies

amyloid deposition

amyloid plaques

amyloid-related imaging abnormalities

amyotrophic lateral sclerosis

anemia

aneurysm

aneurysm, intracranial

aneurysm, intracranial, treatment of

angiitis, granulomatous of CNS

angiotensin-converting enzyme

ankylosing spondylitis

anti GQ1b IgG antibody

anti JC virus antibodies

anti-amyloid therapy

anticonvulsants

antineutrophil cytoplasmic autoantibodies

area postrema syndrome

arteriopathy

arteritides

arteritis, temporal

arteritis, temporal, recurrent

atherosclerosis, accelerated

atherosclerosis, premature

atypical

autism

autoantibodies

autoimmune basal ganglia encephalitis

autoimmune disease

autoimmune encephalopathy

autonomic dysfunction

azathioprine

B cell lymphocyte depletion

B cell lymphocytes

bacterial infection, CNS

basal ganglia

basal ganglia, hemorrhage

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

behavioral disorder, acute

blood dyscrasias, neurologic findings with

bone marrow transplantation

brachial plexus injury

brachial plexus neuropathy

brain atrophy

brain biopsy

brain biopsy, false negative

brain biopsy, negative

calcification, intracranial

calcitonin gene related peptide

calcitonin gene-related peptide receptor blocker

cancer associated myopathy

cancer, cerebrovascular accident complicating patients with

cardiac surgery, neurologic complications with

cardiac transplantation

cardiotoxicity

carotid artery atherosclerosis

carotid artery disease

CAT scan, contrast enhanced, subepend.

CAT scan, emission, abnormal

catatonia

cauda equina

cauda equina, enhancement

cauda equina, lesion of

cavernous sinus

cavernous sinus, metastasis to

central nervous system, infection of

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellitis

cerebellitis, autoimmune

cerebellum, disease of

cerebral arteries

cerebral atherosclerosis

cerebral cortex

cerebral cortical atrophy

cerebral edema

cerebral edema, vasogenic

cerebral hypersensitivity, delayed

cerebral infarction, hemorrhagic

cerebral ischemia

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS tumors

cerebrospinal fluid, cytology

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, infancy and childhood

cerebrovascular accident, recurrent

cerebrovascular accident, secondary prevention

cerebrovascular accident, young adult

cerebrovascular disease

cerebrovascular disease, risk factors in

chemotherapy, CNS treatment and complications with

chest x-ray, abnormal

chromosomal abnormality

cladribine

Clinical Pathologic Conference(C.P.C.)

cluster headache

cognition

coinfection

collapsin response mediator protein 5 IgG

confusional state, acute

congenital malformation

congestive heart failure

contraindications

controversies in neurology

cop 1

corneal dystrophy

Cornelia de Lange syndrome

coronavirus

corpus callosum, lesion of

C-reactive protein, elevated

critical care unit

cyclophosphamide

cyclosporine

cyst, epidermoid of CNS

cytokines

cytomegalovirus infection

dementia, rapidly progressive

dementia, reversible

dementia, treatment of

demyelinating disease

dentate nuclei

dentate nuclei, lesion of

dermatomyositis

developmental milestones

developmental milestones, loss of

diabetes insipidus

diagnostic criteria

diarrhea

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disease modifying agents

diurnal variation

dizziness

donanemab

DPPX, antibodies, encephalitis

drug abuse

drug holiday

drug induced neurologic disorders

drug withdrawal

dyskinesia

dyskinesia, buccal lingual facial

electroencephalogram, abnormalities of

electron microscopy

encephalitis

encephalitis, acanthamoeba

encephalitis, amebic

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, etiology

encephalitis, paraneoplastic

encephalitis, viral

encephalopathy

encephalopathy, anoxic

encephalopathy, delayed

eosinophilia

ependymoma

epidemiology of neurology

Epstein-Barr virus, negative

eptinezumab

erenumab

etanercept

evidence-based research

extralimbic encephalitis

eye movement, painful

face, numbness of

facial nerve palsy

facial nerve palsy, bilateral

facial pain

faciobrachial dystonic seizure

fluorescein angiography

fremanezumab

frexalimab

fumarate

fungal infection, CNS

gamma amino butyric acid receptor antibody

gammaglobulin therapy, intravenous

glioblastoma multiforme(astrocytoma Gr.III)

glioma

glioma, low-grade

glutamic acid decarboxylase, antibody

GM1 ganglioside antibodies

granulomatosis with polyangiitis

granulomatous disease

granulomatous hypophysitis

growth retardation

Guillain Barre syndrome

Guillain Barre syndrome, etiology of

gyral hemorrhage

hallucination

hallucination, olfactory

headache

headache, children

headache, episodic

headache, preventive treatment

headache, prophylaxis

headache, recurrent

headache, severe

headache, sudden onset of

headache, treatment of

hemiplegia, progressive

hemoglobinuria

hemolysis

hemosiderosis of CNS, superficial

hepatic failure

heralding manifestation

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex virus infection, immunosuppressed patient

herpes zoster

hiccoughs

highly active antiretroviral therapy

hippocampus

HLA

Hodgkin's disease

human immunodeficiency virus type 1

hydrocephalus

hypercalcemia

hypercoagulable state

hyperekplexia

hypereosinophilic syndrome(HES)

hypersensitivity reaction

hypertension

hypertrophic intracranial pachymeningitis

hypothalamus, lesion of

iatrogenic neurologic disorders

idiopathic thrombocytopenic purpura

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunocompetent

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

in situ hybridization

inappropriate antidiuretic(A.D.H.)hormone

inborn errors of metabolism, screening

intellectual deterioration

internal carotid artery

intracerebral hemorrhage

intracerebral hemorrhage, causes of

intracerebral hemorrhage, differential diagnosis of

intracerebral hemorrhage, lobar

intracerebral hemorrhage, multiple

intracerebral hemorrhage, small

intracranial pressure, increased

intrathecal chemotherapy

JC virus cerebellar granule cell neuronopathy

JC virus encephalopathy

Klinefelter's syndrome

lactic dehydrogenase(LDH)

laminar necrosis, cortical

laquinimod

lecanemab

leucine rich glioma inactivated 1 antibodies

leukemia, neurologic findings assoc.with

leukoencephalopathy

leukoencephalopathy, toxic

levamisole

level of consciousness, decreased

life expectancy

limbic encephalitis

lipoprotein receptor-related protein 4

listeria monocytogenes

lymph node biopsy

lymphadenopathy

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

lymphomatoid granulomatosis

lymphopenia

malaria

malaria, cerebral

mediastinum, lymph-node biopsy

mediastinum, mass of

medication withdrawal

medulla oblongata

medulla oblongata, lesion of

medulloblastoma

melanoma, malignant

memory, defect of recent

memory, impairment of

meningeal enhancement

meningitis, bacterial

meningitis, basilar

meningitis, carcinomatous

meningitis, children

meningitis, chronic

meningitis, CSF findings in

meningitis, diagnosis

meningitis, drug induced

meningitis, iatrogenic

meningitis, listeria monocytogenes

meningitis, lymphomatous

meningitis, neurologic aspects and complications of

meningitis, neutrophilic

meningitis, noninfectious

meningitis, pneumococcal

meningitis, recurrent

meningitis, TB

meningitis, treatment of

meningoencephalitis

meningoencephalopathy

meningomyelitis

mental status, abnormal

mercaptopurine

mesial temporal lobe

methotrexate

microhemorrhage, intracerebral

microscopic polyangiitis

microsporidia

microsurgery

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebral artery

migraine

migraine, children

migraine, chronic

migraine, intractable

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mild cognitive impairment

mimics

misdiagnosis

molecular genetics

monoclonal antibodies

monoclonal antibodies for tumor cells in CSF

monoclonal gammopathy

mononeuropathy

mononeuropathy multiplex

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, demyelinating disease

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, FLAIR

MRI, magnetization transfer sequence

MRI, mass effect on

MRI, negative

MRI, nodular enhancement

MRI, spinal cord, increased intramedullary cord signal

MRS

multinucleated giant cell

multiple sclerosis

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, etiology of

multiple sclerosis, pathogenesis

multiple sclerosis, plaque

multiple sclerosis, prognosis

multiple sclerosis, relapsing

multiple sclerosis, treatment of

muscle weakness, proximal

MuSK antibodies

mutism

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, drug induced

myasthenia gravis, drug resistant

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myelitis, longitudinal

myelitis, transverse

myelitis, transverse, recurrent

natalizumab, discontinuation

necrotizing vasculitis

negative

neoplasm, intracranial

neoplasm, intracranial with metastasis extracranially

neoplasm, intracranial-incidence and epidemiology of

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS, hemorrhagic

neoplasm, metastatic to CNS-differential diagnosis of

neoplasm, metastatic to CNS-multiple

neoplasm, metastatic to CNS-origin of

neoplasm, metastatic to CNS-prognosis of

neoplasm, metastatic to CNS-recurrent

neoplasm, metastatic to CNS-treatment of

neoplasm, metastatic to CNS-work up for

neoplasm, pituitary

neoplasm, primary intracerebral

neoplasm, primary intracerebral, reoperation

neoplasm, primary intracranial-treatment of

neoplasm, primary of CNS

neoplasm, primary of CNS-children

neoplasm, primary of CNS-classification

neoplasm, primary of CNS-differential diagnosis

neoplasm, primary of CNS-familial occurrence

neoplasm, primary of CNS-incidence of

neoplasm, primary of CNS-recurrent

neoplasm, primary of CNS-surgical treatment of

neoplasm, primary of CNS-survival

neoplasm, primary of CNS-treatment of

nerve biopsy

neurexin-3 alpha antibodies

neuroendocrinology

neurofibromatosis 2

neurofilament light chain protein

neurogenic stunned myocardium

neurologic complications

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuronal cell surface antigen

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, peripheral

neuropathy, peripheral, treatment

neuropathy, sensory

neuropathy, toxic

neuropathy, vasculitic, systemic

nonsteroidal anti-inflammatory drug

nortriptyline

ocrelizumab

oculovestibular reflex

ofatumumab

old age, neurology of

opportunistic infection

opportunistic infection, CNS

optic chiasm

optic chiasm, lesion of

optic nerve, lesion of

optic neuritis

optic neuropathy

optic neuropathy, toxic

oral contraceptives

organ transplantation

pain

pain, abdominal

parasitic infection

parasitic infection, CNS

paresthesias

paroxysmal nocturnal hemoglobinuria

pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

pituitary stalk, enlarged

pituitary, adenoma

plasmapheresis

plasmapheresis, complications of

platelet inhibiting drugs

pleocytosis of cerebrospinal fluid

pleocytosis of cerebrospinal fluid, neutrophilic

pneumonia

POEMS syndrome

polymerase chain reaction

polymerase chain reaction, false negative

polymyalgia rheumatica

polymyositis

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

pontine hemorrhage

post transplant lymphoproliferative disease

posterior leukoencephalopathy syndrome

postoperative neurologic complications

postpartum

postural abnormality

potassium channel antibodies

practice guidelines

precipitating factors

preclinical

pregnancy, neurologic complications in

pretectal syndrome

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

protozoan infection

psoriasis

psoriatic arthritis

psychiatric problems in neurologic disorders

psychological testing

pulmonary infiltrates

radiation encephalopathy, delayed

radiation necrosis

radiation therapy, CNS treatment and complications with

radiation therapy, stereotactic

radiation therapy, total body

radiation vasculopathy

rapidly fatal neurologic illness

rapidly progressing neurologic illness

rash

recurrent

regional enteritis

remote effect of cancer on the nervous system

remternetug

renal transplantation

rheumatoid arthritis, neurologic complications of

rimegepant

risk factors

risk stratification

risk-benefit assessment

sedimentation rate, elevated

seizure

seizure, focal

seizure, intractable

seizure, psychomotor-temporal lobe

serologic testing

serologic testing, false negative

seronegative

seropositive

serotonin agonist

severe acute respiratory syndrome

shared decision making

shoulder, pain in

skin, lesions in neurologic disorders

sleep pathology and physiology

somnolence

speech disorder

speech disorder, childhood

spinal cord

spinal cord, lesion of

splenic-vein thrombosis

splenomegaly

stem cell transplantation

stereotaxic surgery

steroid

steroid responsive encephalitis

steroid therapy, CNS treatment and complications with

stiff joints

striatal encephalitis

striatum, lesion of

striatum, lesion of, bilateral

subarachnoid hemorrhage

temporal lobe, lesion

temporal lobe, lesion, bilateral

teratoma

teratoma, ovarian

thalamus, lesion of

thalamus, lesion of-bilateral

tissue plasminogen activator, intravenous

tocilizumab

toxoplasmosis, acquired

toxoplasmosis, CNS

TRAILBLAZER-ALZ trial

transient ischemic attack

treatment of neurologic disorder

treatment resistant

tremor

trigeminovascular system

triptans

tuberculosis

tumor necrosis factor

tumor necrosis factor inhibitor

unconsciousness

urinary incontinence

uveitis

vaccination, neurologic complications with

vaccine

vagus nerve stimulation

varicella zoster virus

varicella zoster virus, encephalitis

varicella zoster virus, vasculopathy

vascular endothelial growth factor

ventricular assist device

vomiting, intractable

walking, difficulty with

water channel antibodies

weakness

weakness, fatiguable

weakness, focal

weakness, generalized

weakness, unilateral

weight loss

white matter disease

white matter disease, subcortical

workup

Showing articles 50 to 100 of 6277 << Previous Next >>

Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab
Emerg Inf Dis 24:1594-1596, Martinot, M.,et al, 2018

Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma
Case Rep Neurol Med 2018;doi:10.1155/2018/2548528, Shah, S.,et al, 2018

Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody-Positive Myasthenia Gravis
JAMA Neurol 74:60-66, Robeson, K.R.,et al, 2017

Autoimmune Encephalitides: A Broadening Field of Treatable Conditions
Neurologist 22:1-13, Kalman, B., 2017

Natalizumab-Associated PML
Neurol 88:1197-1205, Schwab, N.,et al, 2017

Alemtuzumab CARE-MS I 5-year follow-up
Neurol 89:1107-1116, Havrdova, E.,et al, 2017

Alemtuzumab CARE-MS II 5-year follow-up
Neurol 89:1117-1126, Coles, A.J.,et al, 2017

Rituximab as Treatment for anti-MuSK myasthenia gravis
Neurol 89:1069-1077, Hehir, M.K.,et al, 2017

Infliximab for the Treatment of CNS Sarcoidosis
Neurol 89:2092-2100, Gelfand, J.M.,et al, 2017

CGRP - The Next Frontier for Migraine
NEJM 377:2190-2191, Hershey, A.D., 2017

Clinicopathologic Conference, Paroxysmal Nocturnal Hemoglobinuria
NEJM 377:2581-2590, Case 40-2017, 2017

Acute Cholecystitis During Treatment with Alemtuzumab in 3 Patients with RRMS
Neurol 87:2380-2381, Pfeuffer, S.,et al, 2016

Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS
Neurol 87:1464-1472, Arnold, D.L.,et al, 2016

Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016

Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Eur J Cancer 54:139-148, Michot, JM,.,et al, 2016

Acute Demyelinating Polyneuropathy Caused by Nivolumab in a Man with Metastatic Non-Small Cell Lung Cancer
J Gerontol Geriatr Res 5:3, Sabeeh-Ur-Rehman, B. & Bhaumik, S., 2016

Natalizumab-Related PML 2 Weeks after Negative Anti-JCV Antibody Assay
Neurol 86:484-486, Gagne, M.S.,et al, 2016

Rituximab Treatment for Autoimmune Limbic Encephalitis in an Institutional Cohort
Neurol 86:1683-1691,1655, Lee, W.J.,et al, 2016

Tocilizumab for Induction and Maintenance of Remission in Giant Cell Arteritis: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 387:1921-1927,1882, Villiger, P.M.,et al, 2016

Clinicopathologic Conference, Neurosarcoidosis
NEJM 374:1966-1975, Case 15-2016, 2016

Fulminant Central Nervous System Nocardiosis in a Patient Treated with Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
JAMA Neurol 73:757-759, Penkert, H.,et al, 2016

Radiation Necrosis in Pediatric Patients with Brain Tumors Treated with Proton Radiotherapy
AJNR 36:1572-1578, Kralik, S.F.,et al, 2015

Recurrent Stroke in Childhood Cancer Survivors
Neurol 85:1056-1064, Fullerton, H.J.,et al, 2015

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015

Newer Agents in the Treatment of Multiple Sclerosis
Neurologist 19:104-117, Pawate, S. & Bagnato F., 2015

Effect of Rituximab in Patients with Leucine-Rich, Glioma-Inactivated 1 Antibody-Associated Encephalopathy
JAMA Neurol 71:896-900, Irani, S.R.,et al, 2014

Antiamyloid Therapy for Alzheimers Disease - Are We on the Right Road?
NEJM 370:377-378, Karran, E. & Hardy, J., 2014

Daclizumab-Induced Adverse Events in Multiple Organ Systems in Multiple Sclerosis
Neurol 82:984-988, Oh, J.,et al, 2014

Treatment of Primary CNS Vasculitis with Rituximab: Case Report
Neurol 82:1287-1288, Salvarani, C.,et al, 2014

Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab
JAMA Neurol 71:954-960, Clerico, M.,et al, 2014

Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Sarcoidosis
Adams & Victors Principles of Neurology, Chp 32, pg 721, Ropper, A.H.,et al, 2014

Bevacizumab in Glioblastoma - Still Much to Learn
NEJM 370:764-765, Fine, H.A., 2014

Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014

Sarcoidosis Presenting as Longitudinally Extensive Myelitis
Neurol 81:e61, Goenka, N. & Venna N., 2013

Tumor Necrosis Factor-Alpha Inhibitors: An Overview of Adverse Effects
UpToDate January, Stone, J.H., 2013

Tumor Necrosis Factor-Alpha Inhibitors: Risk of Malignancy
UpToDate January, Stone, J.H., 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:190-194, Gold, R.,et al, 2013

Varicella-Zoster Virus Acute Myelitis in a Patient with MS Treated with Natalizumab
Neurol 80:1812-1813, Yeung, J.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013

Neurological Immune-Related Adverse Events of Ipilimumab
Pract Neurol 13:278-280, Bot, I.,et al, 2013

Herpes Encephalitis During Natalizumab Tretament in Multiple Sclerosis
Mult Scler J 18:909-911, Kwiatkowski, A.,et al, 2012

Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas are Associated with Improved Survival Compared with Matched Controls
AJNR 33:1763-1770, Mong, S.,et al, 2012

Fatal Varicella-Zoster Virus Vasculopathy Associated with Adalimumab Therapy
Arch Neurol 69:1193-1196, Baek, W.,et al, 2012

PML-IRIS in a patient treated with Brentuximab
Neurol 79:2075-2077, Geldern, G.,et al, 2012

Long-lasting Treatment Effect of Rituximab in MuSK Myasthenia
Neurol 78:189-193, Diaz-Manera,J.,et al, 2012

Natalizumab-Associated PML Identified in the Presymptomatic Phase Using MRI Surveillance
Neurol 78:507-508, Blair,N.F.,et al, 2012

Fatal PML Associated with Efalizumab Therapy
Neurol 78:458-467, Schwab,N.,et al, 2012

Treatment of Behcets Disease
UpToDate, Jan, Smith, E.L. & Yazici, Y., 2012

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEJM 366:1870-1880,1938, Bloomgren, G.,et al, 2012

Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012

Showing articles 50 to 100 of 6277 << Previous Next >>